Subscribe Now Subscribe Today
Fulltext PDF
Research Article
Some Lysosomal Enzyme Profiles in Children with Nephroblastoma: The Effect of Nephrectomy

Donatien Gatsing, H. Ibrahim Garba , Roseline Aliyu , H. Abiodun Adebayo , P. Obekpa and I. Godwin Adoga
The serum levels of some lysosomal enzymes-namely β-glucuronidase (EC, β-galactosidase (EC and acid phosphatase (EC measured in controls, pre-operative and post-operative nephroblastoma patients. β-glucuronidase activity showed a significant (p<0.05) increase before surgical intervention, followed by significant (p<0.05) decreases 24 h, 72 h and 7 days after operation. The activities of β-galactosidase and acid phosphatase showed no significant (p>0.05) changes before and after surgical intervention. These data indicate that nephroblastoma and surgery may have a marked effect on the serum levels of some lysosomal enzymes.
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Donatien Gatsing, H. Ibrahim Garba , Roseline Aliyu , H. Abiodun Adebayo , P. Obekpa and I. Godwin Adoga , 2007. Some Lysosomal Enzyme Profiles in Children with Nephroblastoma: The Effect of Nephrectomy. Trends in Medical Research, 2: 51-56.

DOI: 10.3923/tmr.2007.51.56



Nephroblastoma is one of the most common malignant tumour of the kidney and presents in the first decade and often in the first year of life, most commonly as an abdominal mass (Davison and Lambie, 1991). It is an embryonic type of tumour derived from kidney rudiments and forms a large well-circumscribed growth which rapidly invades blood vessels (Govan et al., 1991). Nephroblastoma is the most common renal neoplasm in children, accounting for about 90% of paediatric kidney tumours and 6% of all childhood cancers (Anglesio et al., 2004).

Disease states usually lead to moderate or extensive tissue damage depending on the time of onset and severity of the disease (Garba et al., 2006). The major factor known to be responsible for changes in serum levels of intracellular enzymes is injury to organs or tissues rich in such enzymes (Garba et al., 2005a). Such conditions are usually associated with the release of enzymes from the diseased organ or tissue into circulation. The consequence is an increase in activity of such enzymes in body fluids (Garba et al., 2005b; Gatsing et al., 2005). Thus, measurement of enzymatic activity in serum/plasma and other body fluids has been employed in the diagnosis of diseases (Garba et al., 2006). Enzymatic methods have proven to be crucial to the diagnosis of acute myocardial infarction (Adams et al., 1994; Garba et al., 2005b), liver diseases (Castaldo et al., 1994) and acute pancreatitis (Patenghini and Pagani, 1989). Apart from their value as general diagnostic indicators, enzyme activity measurements in body fluids are providing scientists and clinicians with new insights into the pathological basis of some diseases (Garba et al., 2006). In some instances, they are used as predictors of the progress of diseases, particularly certain types of cancers (Gatsing et al., 2000, 2002, 2003; Garba et al., 2005a). The activity of lysosomal enzymes is increased in body fluids during inflammation, in which cellular malfunction and cellular death occur (Vlacha et al., 2004).

Although the value of the use of lysosomal enzymes excreted in urine as non-invasive tests for renal nephropathy has been documented by several authors (Kunin et al., 1978; Price, 1982; Adoga and Glew, 1995), little is known specifically about the serum activities of lysosomal enzymes in nephroblastoma.

In the present study, we measured the serum activities of three different lysosomal hydrolases-namely β-glucuronidase (EC, β-galactosidase (EC and acid phosphatase (EC pre-operative and post-operative patients suffering from nephroblastoma, with a view to assessing the effect of the disease and surgery (nephrectomy) on these enzyme levels, that might prove valuable as non-invasive means of monitoring this pathological condition.


Blood Specimens and Serum Preparation
Blood samples for enzyme analyses were obtained from 3- to 7- year-old pre-operative and post-operative male patients, in the paediatrics wards of the Jos University Teaching Hospital (JUTH), suffering from nephroblastoma (n = 11). All of these patients had cancer on one kidney only and they underwent unilateral nephrectomy. Normal control blood samples were collected from healthy male individuals (n = 11), which were within the same age group with the patients. The blood samples were then transferred into clean, sterile centrifuge tubes and allowed to clot. Each clotted sample was centrifuged at 3000 g for 10 min to obtain the serum. Enzyme assay was carried out within 24 h of collection.

Enzyme Assays
The serum activities of the three lysosomal enzymes were assayed fluorometrically by estimating the amount of 4-methylumbelliferone released from the appropriate substrate. The β-glucuronidase activity was determined in a reaction medium that contained 10 mM 4-methylumbelliferyl-β-D-glucuronide in 1 M sodium acetate buffer (pH 4.8). The β-galactosidase activity was determined using an incubation medium which contained 3.33 mM 4-methylumbelliferyl-β-D-galactoside in citrate- phosphate buffer with 0.2 M sodium chloride (pH 4.4). The acid phosphatase activity was determined using an incubation medium which contained 10 mM 4-methylumbelliferyl-phosphate in 1 M sodium acetate buffer (pH 4.5). Serum (10 μL) was added to 90 μL of incubation mixture for each enzyme assay. All assays were performed at 37°C; The incubation time being 30 min for β-glucuronidase and β-galactosidase and 15 min for acid phosphatase. The reactions were terminated by adding 2.9 mL of 0.3 M glycine/ammonia buffer (pH 10.0), to make a final volume of 3.0 mL.

The amount of 4-methylumbelliferone liberated was measured fluorometrically as described elsewhere (Adoga and Glew, 1995; Gatsing et al., 2000, 2002, 2003; Gatsing and Adoga, 2004) using a Turner fluorometer, model III (Sequoia-Turner Corp., Mountain View, CA), with excitation at 360 nm and emission at 520-580 nm. The assays are highly reproducible and have a standard error of less than 4% (VanderJagt et al., 1992; Adoga and Glew, 1995; Yazzie et al., 1995; Gatsing et al., 2000; Gatsing et al., 2002; Gatsing et al., 2003; Gatsing and Adoga, 2004; Gatsing et al., 2006). Serum enzyme activities were expressed as nmole/h/mL serum. Results for both the patients and the controls are expressed as the mean±1 standard deviation (SD).

Statistical Analysis
Statistical analyses were performed with the aid of the Number Cruncher Statistical System software program (NCSS, version 5, Kaysville, UT). Group comparisons were done using the Mann-Whitney two-sample test and One-way analysis of variance (ANOVA). A p-value of <0.05 was considered statistically significant.

This work was conducted in accordance with the following ethical declarations:

World Medical Association's Declaration of Helsinki (WMA, 1996).
APA Ethical Principles in the Conduct of Research with Human Participants (APA, 1982).
World Medical Association's Declaration of Lisbon on the Rights of the Patient (WMA, 1995).
CIOMS/WHO International Guidelines for the Conduct of Research Involving Human Subjects (CIOMS/WHO, 1993).

Moreover, samples were obtained after the research protocols had been approved by the Department of Surgery at JUTH. Besides, informed consent was obtained from one of the relations of each patient after explanation of the purpose of the study.


Patients with Wilms’ tumour showed a significant (p<0.05) increase in β-glucuronidase activity before surgical operation, as compared to control values. This was followed by significant (p<0.05) decreases in β-glucuronidase activities 24, 72 h and 7 days after surgical intervention, as compared to pre-operation values. The activity of β-glucuronidase observed 7 days after operation was still significantly (p<0.05) higher than the control value (Table 1).

β-Galactosidase activity showed a slight increase before operation, but which was not statistically significant (p>0.05), as compared to control value. This was followed by a slight decrease 24 h after operation, which still was not statistically significant (p>0.05), as compared to pre-operation value.

Acid phosphatase activity showed a decrease before operation, but which was not statistically significant (p>0.05), as compared to control value. The activity of this enzyme was found to be increased after surgical intervention, but still this increase was not statistically significant (p>0.05), as compared to pre-operation value (Table 1).

Table 1: Serum activities of some lysosomal enzymes in Wilms’ tumour patients before and after surgical operation
Tabulated values are Mean±SD of eleven independent determinations, Key: a: p<0.05 vs control; b: p<0.05 vs pre-operation values


Not much work has been done on the effect of the disease and surgery on the serum levels of lysosomal enzymes in nephroblastoma. However, it is known that kidney damage leads to the urinary excretion of abnormally high activities of β-hexosaminidase and β-galactosidase (Price et al., 1970; Wellwood et al., 1976), as has been shown for rats injected with nephrotoxic agents (Dance et al., 1970). Urinary β-glucuronidase has been found to be a useful marker of renal injury and disease (Kunin et al., 1978; Plummer et al., 1986) because of its high molecular weight and presence in high concentrations in the kidney (Yazzie et al., 1995).

Proliferation of cells, an increase in the rate of cell turnover, cell damage or an increase in the rate of enzyme induction and synthesis and their reduced clearance result in increased serum/plasma enzyme concentrations (Balami et al., 1998).

The data obtained in the present study revealed that in nephroblastoma patients, serum activity of β-galactosidase showed a slight increase before operation and a slight decrease after operation, all of which were not statistically significant as compared to control and pre-operation values, respectively. In contrast, acid phosphatase activity showed a decrease before operation and an increase after operation, all of which still were not statistically significant as compared to control and pre-operation values, respectively. This result suggests that the disease and surgery may have a selective effect on lysosomal enzymes.

The most interesting result here was the finding of a significant increase in β-glucuronidase activity in the serum of patients before operation as compared to control values (257.8±72.2 for control and 979.7±106.9 for patients); The pre-operation values being about 4-fold higher than the control values. The medical report did not show any metastases in these patients. An increased activity of lysosomal enzymes in the blood is indicative of pathologic changes on tissues (Raulo et al., 1996). The increased release of β-glucuronidase into the bloodstream of nephroblastoma patients may therefore be due to tissue damage or necrosis created by the disease. This may also be due to the effect of the underlying pathological condition on the state of the lysosomal membrane. Besides, β-glucuronidase serum activity showed significant decreases 24, 72 h and 7 days after operation as compared to pre-operation values. Also, the medical report indicated some improvement in the patients’ conditions after surgical intervention. A decrease in the blood level of this enzyme after operation may therefore indicate recovery from the disease. Hence, the variations in β-glucuronidase activity in the serum may prove valuable in monitoring progress in nephroblastoma.


We wish to express our gratitude to Dr. Ramyil of the Department of Surgery, Dr. Liman and Dr. Ekpo, all of the Jos University Teaching Hospital (JUTH)-Nigeria, for their co-operation during sample collection.

APA, 1982. Committee for the Protection of Human Participants in Research. Ethical Principles in the Conduct of Research With Human Participants. American Psychological Association, Washington, DC.

Adams, J.E., K.B. Schectman, J.H. Landt and A.S. Jaffe, 1994. Comparative detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin. Clin. Chem., 40: 1191-1195.

Adoga, G.I. and R.H. Glew, 1995. Lysosomal Enzymes in the Diagnosis and Management of Complications in Diabetes Mellitus. International Diabetes Digest, UK., pp: 12-15.

Anglesio, M.S., V. Evdokimova, N. Melnyk, L. Zhang and C.V. Fernandez et al., 2004. Differential expression of a novel ankyrin containing E3 Ubiquitin-protein ligase, Hace1, insporadic Wilms tumor versus normal kidney. Human Mol. Genet., 13: 2061-2074.
PubMed  |  Direct Link  |  

Balami, D., G.I. Adoga and S.E. Okpe, 1998. Changes in lysosomal enzymes activities in paediatric patients in Jos, Nigeria West Afr. J. Biol. Sci., 7: 156-160.

CIOMS/WHO (Council of International Organization of Medical Sciences/World Health Organization), 1993. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva.

Castaldo, G., G. Oriani, L. Cimino, M. Topa and I. Mostarda et al., 1994. Total discrimination of peritoneal malignant ascites from cirrhosis and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase. Clin. Chem., 40: 478-483.
Direct Link  |  

Dance, N., R.G. Price, W.R. Cattell, J. Lansdell and B. Richards, 1970. The excretion of N-acetyl-β-D-glucosaminidase and β-galactosidase by patients with renal disease. Clinica Chimica Acta, 27: 87-92.

Davison, A.M. and A.T. Lambie, 1991. Diseases of the Kidney and Genito-Urinary System. In: Davidson's Principles and Practice of Medicine, Edwards, C.R.W. and I.A.D. Bouchier (Eds.). 16th Edn., Churchill Livingstone, Edinburgh, pp: 547-606.

Garba, I.H., D. Gatsing and G. Ubom, 2006. Elevated total and isoenzyme forms of acid phosphatase in falciparum malaria. Comptes Rendus Biol., 329: 75-78.
Direct Link  |  

Garba, I.H., D. Gatsing, Awwal and J. Gadzama, 2005. Alanine and aspartate transaminases in the serum of acute appendicitis patients before and after surgery. Int. J. Gastroenterol., 4: 1-1.
Direct Link  |  

Garba, I.H., G. Ubom, D. Gatsing and M. Awwal, 2005. Acid phosphatase activity as a potential prognostic marker in patients with Benign Prostate Hyperplasia (BPH). Int. J. Surg., 6: 1-3.
Direct Link  |  

Gatsing, D. and G.I. Adoga, 2004. Lysosomal enzymuria in the diagnosis and monitoring of diabetic nephropathy. L`Eurobiologiste, 35: 1-4.
Direct Link  |  

Gatsing, D., G.I. Adoga and P. Obekpa, 2002. β-glucuronidase, β-galactosidase and acid phosphatase activities in liposarcoma patients before and after surgical intervention. L`Eurobiologiste, 35: 11-14.
Direct Link  |  

Gatsing, D., G.I. Adoga, B. Dondji, P. Obekpa, 2003. Effect of surgical intervention on levels of β-galactosidase and β-glucuronidase in patients with prostatic carcinoma. Ann. Fac. Sci. Univ. Yaounde I, 35: 29-32.

Gatsing, D., G.I. Adoga, I.H. Garba, P. Obekpa and Y.K. Towa, 2000. The use of acid phosphatase in the monitoring of laryngeal carcinoma. L'Eurobiologiste, 34: 31-34.
Direct Link  |  

Gatsing, D., I.H. Garba and G.I. Adoga, 2006. The use of lysosomal enzymuria in the early detection and monitoring of the progression of diabetic nephropathy. Indian J. Clin. Biochem., 21: 42-48.
CrossRef  |  Direct Link  |  

Gatsing, D., R. Aliyu, J.R. Kuiate, I.H. Garba and K.H. Jaryum et al., 2005. Toxicological evaluation of the aqueous extract of Allium sativum bulbs on laboratory mice and rats. Cameroon J. Exp. Biol., 1: 39-45.
Direct Link  |  

Govan, A.D.T., P.S. Macfarlane and R. Callander, 1991. Pathology Illustrated. 3rd Edn., Livingstone, Churchill.

Kunin, C.M., R.W. Chesney, W.A. Craig, A.C. England and C. DeAngelis, 1978. Enzymuria as a marker of renal injury and disease: Studies of N-acetyl-βglucosaminidase in the general population and in patients with renal disease. Pediatrics, 62: 751-760.
Direct Link  |  

Patenghini, M. and F. Pagani, 1989. Diagnostic value of measuring pancreatic lipase and the P3 isoform of the pancreatic amylase isoenzyme in serum of hospitalized hyperamylasemic patients. Clin. Chem., 35: 417-421.
Direct Link  |  

Plummer, D.T., S. Noorazar, D.K. Obatomi and J.D. Haslam, 1985. Assessment of renal injury by urinary enzymes. Uraemia Invest., 9: 97-102.
CrossRef  |  Direct Link  |  

Price, R.G., 1982. Urinary enzymes, nephrotoxicity and renal disease. Toxicology, 23: 99-134.
CrossRef  |  Direct Link  |  

Price, R.G., N. Dance, B. Richards and W.R. Cattell, 1970. The excretion of N-Acetyl-β-D-glucosaminidase following surgery to the kidney. Clin. Chim. Acta, 27: 65-72.

Raulo, S.M., S. Hyyppa, L.A. Rasanen and A.R. Poso, 1996. Exercise-induced changes in the activities of β-glucuronidase and N-acetyl-β-D-glucosaminidase in plasma and muscle of standardbred trotters. Zentralbl-Veterinarmed A., 43: 119-126.

VanderJagt, D.J., B.R. Steinberg and R.H. Glew, 1992. Comparison of urinary excretion of four lysosomal hydrolases in healthy elderly and young adults. Clin. Chim. Acta, 210: 47-54.
PubMed  |  Direct Link  |  

Vlacha, V., M. Eliopoulou, S. Haidas and N.G. Beratis, 2004. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate. Pediatr. Blood Cancer, 42: 350-356.
PubMed  |  Direct Link  |  

WMA (World Medical Association), 1995. Declaration on the Rights of the Patient Amended by the 43rd General Assembly. Bali.

WMA (World Medical Association), 1996. Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki; Finland, June 1964 and Amended by the 48th General Assembly, October 1996, Somerset West.

Wellwood, J.M., D. Lovell, A.E. Thompson and J.R. Tighe, 1976. Renal damage caused by gentamicin: A study of the effects on renal morphology and urinary enzyme excretion. J. Path., 118: 171-181.

Yazzie, D., G.I. Adoga, A. Okolo, R. Szlachetka, D. Fry and R.H. Glew, 1995. Decreased urinary excretion of β-glucuronidase in sickle cell anemia in Nigeria. Renal Failure, 17: 57-64.
Direct Link  |  

©  2017 Science Alert. All Rights Reserved
Fulltext PDF References Abstract